OTCMKTS:APHQFAphria Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aphria Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume7.14 million shsAverage Volume2.53 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsHeadlinesSocial Media Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Aphria. Previous Next 3.2 Community Rank Outperform VotesAphria has received 148 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAphria has received 81 “underperform” votes. (Add your “underperform” vote.)Community SentimentAphria has received 64.63% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote “Outperform” if you believe APHQF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APHQF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAphria does not currently pay a dividend.Dividend GrowthAphria does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aphria insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.14% of the stock of Aphria is held by institutions. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Agricultural Commodities/Milling Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:APHQF Previous Symbol CUSIPN/A CIKN/A WebN/A Phone(844) 427-4742Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:APHQF Rates by TradingView Receive APHQF News and Ratings via Email Sign-up to receive the latest news and ratings for APHQF and its competitors with MarketBeat's FREE daily newsletter. Aphria (OTCMKTS:APHQF) Frequently Asked Questions Has Aphria been receiving favorable news coverage? News headlines about APHQF stock have trended extremely positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aphria earned a daily sentiment score of 5.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutAphria. Who are some of Aphria's key competitors? Some companies that are related to Aphria include 1933 Industries (TGIF), 21st North (ULGX), 89bio (ETNB), AAC Technologies (ABSCF), Abacus Health Products (ABAHF), Abattis Bioceuticals (ATT), Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Acreage (ACRGF), Admedus (AHZ), Advanz Pharma (CXRXF), AEGON (AGN), Aeolus Pharmaceuticals (AOLS) and Affymax (AFFY). View all competitors. Who are Aphria's key executives? Aphria's management team includes the following people: Mr. Victor Neufeld, Chair of the Board of Directors, CEO & Pres (Age 64)Mr. Cole Cacciavillani, Co-Founder, VP of Growing Operations & Director (Age 63)Mr. John Cervini, Co-Founder, VP of Infrastructure & Technology and DirectorMr. Carl A. Merton, Chief Financial OfficerMs. Megan McCrae, Director of Marketing What is Aphria's stock symbol? Aphria trades on the OTCMKTS under the ticker symbol "APHQF." How do I buy shares of Aphria? Shares of APHQF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. How can I contact Aphria? The company can be reached via phone at (844) 427-4742. This page was last updated on 6/4/2020 by MarketBeat.com Staff
